메뉴 건너뛰기




Volumn 56, Issue 1, 2003, Pages 1-

The pharmacokinetics of voriconazole

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AZITHROMYCIN; CIMETIDINE; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; DIGOXIN; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INDINAVIR; MACROLIDE; OMEPRAZOLE; PHENYTOIN; PROTEINASE INHIBITOR; TRIAZOLE DERIVATIVE; VORICONAZOLE; WARFARIN;

EID: 0344512415     PISSN: 02643774     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01991.x     Document Type: Editorial
Times cited : (12)

References (7)
  • 1
    • 0023687573 scopus 로고
    • Cytochrome P450 of fungi: Primary target for azole antifungal agents
    • Yoshida Y. Cytochrome P450 of fungi: primary target for azole antifungal agents. Curr Top Med 1988; 2: 388-418.
    • (1988) Curr Top Med , vol.2 , pp. 388-418
    • Yoshida, Y.1
  • 3
    • 0031690304 scopus 로고    scopus 로고
    • Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus
    • Cuenca-Estrella M, Rodriguez-Tudela JL, Mellado E, Martinez-Suarez JV, Monzon A. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus. J Antimicrob Chemother 1998; 42: 531-533.
    • (1998) J Antimicrob Chemother , vol.42 , pp. 531-533
    • Cuenca-Estrella, M.1    Rodriguez-Tudela, J.L.2    Mellado, E.3    Martinez-Suarez, J.V.4    Monzon, A.5
  • 4
    • 0344572680 scopus 로고    scopus 로고
    • Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
    • Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999; 43: 149-151.
    • (1999) J Antimicrob Chemother , vol.43 , pp. 149-151
    • Cuenca-Estrella, M.1    Ruiz-Diez, B.2    Martinez-Suarez, J.V.3    Monzon, A.4    Rodriguez-Tudela, J.L.5
  • 5
    • 0035073834 scopus 로고    scopus 로고
    • Voriconazole: A second-generation triazole
    • Chandrasekar PH, Manavathu E. Voriconazole: a second-generation triazole. Drugs Today 2001; 37: 135-148.
    • (2001) Drugs Today , vol.37 , pp. 135-148
    • Chandrasekar, P.H.1    Manavathu, E.2
  • 6
    • 0037855889 scopus 로고    scopus 로고
    • The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human
    • Roffey SJ, Cole S, Comby P et al. The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab Dispos 2003; 31: 731-741.
    • (2003) Drug Metab Dispos , vol.31 , pp. 731-741
    • Roffey, S.J.1    Cole, S.2    Comby, P.3
  • 7
    • 0037403687 scopus 로고    scopus 로고
    • Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
    • Hyland R, Jones BC, Smith DA. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. Drug Metab Dispos 2003; 31: 540-547.
    • (2003) Drug Metab Dispos , vol.31 , pp. 540-547
    • Hyland, R.1    Jones, B.C.2    Smith, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.